We were wrong maybe 20%+ with our new product launch TPPs. The cost of being wrong is huge. Several million dollars. (Product X was a $400 million miss.) This data is hugely valuable – it can help improve our outcomes.

Generic Pharma

SVP NPD

Data available in the 503B space is nonexistent for the market as a whole. There is no clean dataset of the market at a product or pricing level. Today we rely on human intelligence. This data is truly unique and not available anywhere else.

Leading Branded Pharma Co

CMO

“It was a quarterly earnings call and our CFO and CEO were talking about surgeries and admissions volumes in the US in a way that they have never talked about before. We’ve been able to guide them as a result of this data. The level of sophistication from the reports that we’ve gotten has changed the game for us. I couldn’t do my job the same without it anymore.”

Global Pharma Company

CFO